Randal W. Scott insider trades

Open-market stock purchases and sales by Randal W. Scott, Director at BridgeBio Pharma, Inc, from SEC Form 4 filings since Feb 17, 2021.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +8%.

Recent trades

DateStockTradeValue
May 15, 2026BBIO BridgeBio Pharma, IncSold$413K
May 15, 2026BBIO BridgeBio Pharma, IncSold$141K
May 15, 2026BBIO BridgeBio Pharma, IncSold$103K
May 15, 2026BBIO BridgeBio Pharma, IncSold$13.8K
May 15, 2026BBIO BridgeBio Pharma, IncBought (not open market)—
Feb 17, 2026BBIO BridgeBio Pharma, IncSold$141K
Feb 17, 2026BBIO BridgeBio Pharma, IncSold$362K
Feb 17, 2026BBIO BridgeBio Pharma, IncSold$251K
Feb 17, 2026BBIO BridgeBio Pharma, IncBought (not open market)—
Nov 17, 2025BBIO BridgeBio Pharma, IncSold$252K
Nov 17, 2025BBIO BridgeBio Pharma, IncSold$415K
Nov 17, 2025BBIO BridgeBio Pharma, IncBought (not open market)—

Companies traded

  • BBIO BridgeBio Pharma, Inc: 1 buy, 17 sales, last May 15, 2026
  • TLIS Talis Biomedical Corp: 3 buys, last Jun 9, 2023
  • NVTA Invitae Corp: other filings, last Apr 27, 2023

Get free alerts when Randal W. Scott files a new trade →